# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Vernon Bernardino reiterates Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $5 pr...
HC Wainwright & Co. analyst Vernon Bernardino reiterates Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $5 pr...
Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(...
HC Wainwright & Co. analyst Vernon Bernardino maintains Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $5 pri...
Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.99) per share which missed the analyst consensus estimate of ...